M. L. Stama

Most-cited papers

1. Novel Ureidopropanamide Based N-Formyl Peptide Receptor 2 (FPR2) Agonists with Potential Application for Central Nervous System Disorders Characterized by Neuroinflammation

   M. L. Stama, Joanna Œlusarczyk, E. Lacivita, Liliya N. Kirpotina +7 more

   2017European journal of medicinal chemistry46 citations Open access

   Semantic Scholar

   Save

2. Novel 3-(1H-indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]propanamides as Selective Agonists of Human Formyl-Peptide Receptor 2

   E. Lacivita, I. Schepetkin, M. L. Stama, Liliya N. Kirpotina +5 more

   2014Bioorganic & Medicinal Chemistry15 citations Open access

   Semantic Scholar

   Save

3. Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome.

   E. Lacivita, M. Niso, M. L. Stama, Anna L. Arzuaga +6 more

   2020European journal of medicinal chemistry14 citations Open access

   Semantic Scholar

   Save

4. Functional N-Formyl Peptide Receptor 2 (FPR2) Antagonists Based on Ureidopropanamide Scaffold Have Potential to Protect Against Inflammation-associated Oxidative Stress

   M. L. Stama, E. Lacivita, Liliya N. Kirpotina, M. Niso +4 more

   2017ChemMedChem13 citations Open access

   Semantic Scholar

   Save

5. Novel highly potent serotonin 5-HT7 receptor ligands: structural modifications to improve pharmacokinetic properties.

   E. Lacivita, Pantaleo Di Pilato, M. L. Stama, N. Colabufo +7 more

   2013Bioorganic & Medicinal Chemistry Letters6 citations Open access

   Semantic Scholar

   Save